02172.HK
MicroPort NeuroTech Limited
HKSE · Healthcare · Medical - Devices · CN
HKD 8.06
+0.00%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 1.5B | 770.0M | 761.8M | 665.6M | 547.4M |
| Cost of Revenue | 413.9M | 204.3M | 205.8M | 153.8M | 154.3M |
| Gross Profit | 1.1B | 565.7M | 555.9M | 511.8M | 393.0M |
| Operating Expenses | |||||
| R&D Expense | 173.8M | 75.9M | 96.5M | 165.1M | 123.3M |
| SG&A Expense | 417.2M | 230.8M | 188.3M | 166.9M | 154.5M |
| General & Admin Expense | 87.6M | 63.0M | 55.8M | 56.1M | 67.7M |
| Selling & Marketing Expense | 212.2M | 167.8M | 132.5M | 110.7M | 86.8M |
| Other Expenses | (81.3M) | (6.0M) | (55.7M) | (40.0M) | (6.4M) |
| Total Operating Expenses | 509.7M | 300.7M | 229.1M | 292.0M | 271.3M |
| Cost and Expenses | 923.6M | 505.0M | 434.9M | 445.8M | 425.6M |
| Operating Income (EBIT) | 622.3M | 265.0M | 326.8M | 219.8M | 121.7M |
| Non-Operating | |||||
| Interest Income | 30.2M | 15.2M | 15.9M | 16.6M | 10.0M |
| Interest Expense | 91.4K | 1.6M | 3.5M | 3.5M | 99.3M |
| Net Interest Income | 28.4M | 13.6M | 12.3M | 13.1M | (89.5M) |
| Other Non-Op Income/Expense | (90.3M) | (40.0M) | (24.1M) | (57.8M) | (126.0M) |
| Non-Operating Income (excl Interest) | 38.3M | — | 27.0M | 54.3M | (11.6M) |
| EBT (Pre-Tax Income) | 531.9M | 225.0M | 302.7M | 162.1M | (4.3M) |
| Income Tax Expense | 100.7M | 46.0M | 53.9M | 27.5M | 20.4M |
| Bottom Line | |||||
| Net Income | 437.3M | 179.7M | 254.2M | 145.5M | (21.8M) |
| Earnings from Cont. Ops | 431.1M | 179.0M | 248.9M | 134.6M | (24.7M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 437.1M | 179.7M | 254.2M | 145.5M | (21.8M) |
| Per Share | |||||
| Basic EPS | HK$0.75 | HK$0.31 | HK$0.44 | HK$0.25 | (HK$0.04) |
| Diluted EPS | HK$0.75 | HK$0.31 | HK$0.44 | HK$0.25 | (HK$0.04) |
| Revenue Per Share | HK$2.70 | HK$1.35 | HK$1.32 | HK$1.14 | HK$1.06 |
| Shares | |||||
| Basic Shares Outstanding | 572.3M | 570.5M | 579.1M | 582.7M | 517.5M |
| Diluted Shares Outstanding | 572.3M | 571.0M | 579.1M | 582.7M | 517.5M |
| Profitability Metrics | |||||
| EBITDA | 655.3M | 339.0M | 340.5M | 221.6M | 175.5M |
| D&A | 71.3M | 74.0M | 40.6M | 56.1M | 42.2M |
| EBIT | 583.8M | 265.0M | 299.8M | 165.5M | 133.3M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Dec 1, 2025